Search research articles
Contact Us
Filters
Showing results (171-180 of 634) with videos related to
Page
of 64
Sort By:
Veterinary and Comparative Oncology
|
July 4, 2012
Development of a limited-sampling model for prediction of doxorubicin exposure in dogs
L A Wittenburg, D H Thamm, D L Gustafson
Clinical and Experimental Pharmacology & Physiology
|
June 12, 2004
Administration of exogenous tissue plasminogen activator reduces oedema in mice lacking the tissue plasminogen activator gene
Kathleen A Stringer, John S Dunn, Daniel L Gustafson
Preventive Veterinary Medicine
|
June 22, 2005
Using expert opinion to identify risk factors important to infectious salmon-anemia (ISA) outbreaks on salmon farms in Maine, USA and New Brunswick, Canada
L L Gustafson, S K Ellis, C A Bartlett
Veterinary and Comparative Oncology
|
June 11, 2013
Comparative analysis of MAPK and PI3K/AKT pathway activation and inhibition in human and canine melanoma
J S Fowles, C L Denton, D L Gustafson
Cancer Communications
|
September 1, 1991
Role of xanthine oxidase in the potentiation of doxorubicin-induced cardiotoxicity by mitomycin C
D L Gustafson, J D Swanson, C A Pritsos
Journal of the American Academy of Dermatology
|
June 1, 1985
Clinical aspects of cutaneous leishmaniasis acquired in Texas
D A Nelson, T L Gustafson, R L Spielvogel
Cancer Letters
|
March 16, 2005
Pharmacokinetics of combined doxorubicin and paclitaxel in mice
Daniel L Gustafson, Andrea L Merz, Michael E Long
Viral Immunology
|
August 1, 2017
B Cell Tetramer Development for Veterinary Vaccinology
Michael C Rahe, Kevin L Gustafson, Michael P Murtaugh
Analytical Biochemistry
|
February 15, 1988
Use of a Western blotting technique in the purification of a cysteine proteinase inhibitor
M J Korth, D J Finn, G L Gustafson
Acta Neurologica Scandinavica
|
May 1, 1979
EEG and cognitive impairment in presenile dementia
G Johannesson, B Hagberg, L Gustafson, et al.
Page
of 64
Search research articles
Search
Showing results (171-180 of 634) with videos related to
Sort By:
Page
of 64
Veterinary and Comparative Oncology
|
July 4, 2012
Development of a limited-sampling model for prediction of doxorubicin exposure in dogs
L A Wittenburg, D H Thamm, D L Gustafson
Clinical and Experimental Pharmacology & Physiology
|
June 12, 2004
Administration of exogenous tissue plasminogen activator reduces oedema in mice lacking the tissue plasminogen activator gene
Kathleen A Stringer, John S Dunn, Daniel L Gustafson
Preventive Veterinary Medicine
|
June 22, 2005
Using expert opinion to identify risk factors important to infectious salmon-anemia (ISA) outbreaks on salmon farms in Maine, USA and New Brunswick, Canada
L L Gustafson, S K Ellis, C A Bartlett
Veterinary and Comparative Oncology
|
June 11, 2013
Comparative analysis of MAPK and PI3K/AKT pathway activation and inhibition in human and canine melanoma
J S Fowles, C L Denton, D L Gustafson
Cancer Communications
|
September 1, 1991
Role of xanthine oxidase in the potentiation of doxorubicin-induced cardiotoxicity by mitomycin C
D L Gustafson, J D Swanson, C A Pritsos
Journal of the American Academy of Dermatology
|
June 1, 1985
Clinical aspects of cutaneous leishmaniasis acquired in Texas
D A Nelson, T L Gustafson, R L Spielvogel
Cancer Letters
|
March 16, 2005
Pharmacokinetics of combined doxorubicin and paclitaxel in mice
Daniel L Gustafson, Andrea L Merz, Michael E Long
Viral Immunology
|
August 1, 2017
B Cell Tetramer Development for Veterinary Vaccinology
Michael C Rahe, Kevin L Gustafson, Michael P Murtaugh
Analytical Biochemistry
|
February 15, 1988
Use of a Western blotting technique in the purification of a cysteine proteinase inhibitor
M J Korth, D J Finn, G L Gustafson
Acta Neurologica Scandinavica
|
May 1, 1979
EEG and cognitive impairment in presenile dementia
G Johannesson, B Hagberg, L Gustafson, et al.
Page
of 64